Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics

BACKGROUND: The well-established benefit of Low-Dense-Lipoprotein-cholesterol (LDL-c) lowering treatments (LLTs) has led clinical guidelines to lower the cardiovascular prevention targets. Despite this, there is a surprising scarcity of real-world studies (RWS) evaluating whether recommendations are...

Descripción completa

Detalles Bibliográficos
Autores principales: Morieri, Mario Luca, Avogaro, Angelo, Fadini, Gian Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653689/
https://www.ncbi.nlm.nih.gov/pubmed/33172454
http://dx.doi.org/10.1186/s12933-020-01164-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653689/
https://www.ncbi.nlm.nih.gov/pubmed/33172454
http://dx.doi.org/10.1186/s12933-020-01164-8

Ejemplares similares